Reply to: Sustained resolutin of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy

被引：1
|
作者：
Gopal, Deepak V. [1 ]
Rosen, Hugo R.
机构：
[1] Univ Wisconsin, Div Gastroenterol & Hepatol, Madison, WI 53706 USA
[2] Univ Colorado, Div Gastroenterol & Hepatol, Denver, CO 80202 USA
[3] Univ Colorado, Hepatitis C Res Ctr, Denver, CO 80202 USA
来源：
LIVER TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1002/lt.21055
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [21] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263
  • [22] Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
    Foster, GR
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 685 - 691
  • [23] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nobuhiro Aizawa
    Hirayuki Enomoto
    Tomoyuki Takashima
    Yoshiyuki Sakai
    Kazunari Iwata
    Naoto Ikeda
    Hironori Tanaka
    Yoshinori Iwata
    Masaki Saito
    Hiroyasu Imanishi
    Hiroko Iijima
    Shuhei Nishiguchi
    Journal of Gastroenterology, 2014, 49 : 1253 - 1263
  • [24] Comparison of combination therapy of pegylated interferon and ribavirin with conventional interferon and ribavirin in chronic hepatitis C in Korea
    Kang, Myoung Joo
    Jung, Eun Uk
    Park, Sang Won
    Choi, Paul
    Kim, Ji Hyun
    Park, Sung Jae
    Park, Eun Taek
    Lee, Youn Jae
    Lee, Sang Hyuk
    Seol, Sang Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A217 - A217
  • [25] THYROID FUNCTION OUTCOMES AFTER PEGYLATED INTERFERON-α AND RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C
    Tran, Huy A.
    Reeves, Glenn E. M.
    Ianna, Elizabeth A.
    Leembruggen, Nadine
    ENDOCRINE PRACTICE, 2010, 16 (06) : 934 - 939
  • [26] Relapse of hepatitis C in a pegylated-interferon-α-2b plus ribavirin-treated sustained virological responder
    Fujii, Hideki
    Itoh, Yoshito
    Ohnishi, Naoki
    Sakamoto, Masafumi
    Ohkawara, Tohru
    Sawa, Yoshihiko
    Nishida, Koichi
    Nishimura, Takeshi
    Yamaguchi, Kanji
    Yasui, Kohichiroh
    Minami, Masahito
    Okanoue, Takeshi
    Ohkawara, Yasuo
    Yoshikawa, Toshikazu
    HEPATOLOGY RESEARCH, 2010, 40 (06) : 654 - 660
  • [27] Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection
    Kim, Do Young
    GUT AND LIVER, 2014, 8 (04) : 335 - 336
  • [28] Quality of life with pegylated interferon therapy for hepatitis C - Reply
    Bernstein, D
    HEPATOLOGY, 2002, 36 (03) : 768 - 768
  • [29] Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C
    Davis, GL
    SEMINARS IN LIVER DISEASE, 1999, 19 : 49 - 55
  • [30] Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin
    Ei Tae Kim
    Lee Hoo Kim
    Jung Il Lee
    Hee Seung Chin
    Japanese Journal of Ophthalmology, 2009, 53 : 598 - 602
12345